| Net Cash Provided by (Used in) Operating Activities |
$44,484,000 |
USD |
-37% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$53,688,000 |
USD |
30% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$24,982,000 |
USD |
-566% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
300,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
105,383,000 |
shares |
-4.4% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$71,775,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$4,335,000 |
USD |
-81% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,066,000 |
USD |
26% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$77,790,000 |
USD |
-14% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$20,984,000 |
USD |
-78% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid |
$24,597,000 |
USD |
-77% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$3,965,532,000 |
USD |
0.76% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$3,253,000 |
USD |
-91% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$4,259,000 |
USD |
-87% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$4,573,000 |
USD |
-86% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
$5,401,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$3,613,000 |
USD |
-68% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$3,622,000 |
USD |
-86% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$3,190,000 |
USD |
-11% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$76,724,000 |
USD |
-15% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$60,092,000 |
USD |
-13% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |